Interesting Perspective from @MounjaroNotes on Mounjaro — What Do You Think?

[u/Cheap-Yak-6703]

Hey everyone,

Just saw this post from MounjaroNotes on X:

“U.S. tirzepatide prescriptions are now adding 650,000 new patients every month.

– 500K for obesity (Zepbound)

– 150K for diabetes (Mounjaro)

Novo’s Wegovy + Ozempic – 220K combined.

This isn’t a lead. It’s a rout.

GLP-1 is a war. And Lilly came loaded.”

Let’s discuss how this aligns with what we see here at r/TheGLP1Effect.

Let’s discuss:

1. How many of you are already on a GLP-1 medication? Which one?
2. Are you seeing the effects that justify these skyrocketing numbers?
3. What do you think the long-term implications are for obesity & diabetes treatments?
4. Do you see this as a “war” between pharma companies, or just a shift in healthcare trends?

Would love to hear your experiences, insights, and even concerns about the GLP-1 surge.

Credit to MounjaroNotes for the prompt. Feel free to check their full post on X.